Alerce Investment Management’s Whitehawk Therapeutics WHWK Stock Holding History

Alerce Investment Management’s Portfolio WHWK Stock Details WHWK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	$2.08K	Hold	659	–	–	﹤0.01%	5
2024 Q3	$1.36K	Sell	659 -1,630,171	-100%	-$2.64M	﹤0.01%	5
2024 Q2	$2.38M	Hold	1,630,830	–	–	4.67%	5
2024 Q1	$3.82M	Hold	1,630,830	–	–	4.01%	5
2023 Q4	$3.29M	Hold	1,630,830	–	–	4.38%	4
2023 Q3	$7.89M	Hold	1,630,830	–	–	13.49%	4
2023 Q2	$11.2M	Hold	1,630,830	–	–	14.51%	4
2023 Q1	$11.8M	Hold	1,630,830	–	–	15.6%	3
2022 Q4	$20.9M	Buy	1,630,830 +336,045	+26%	+$4.39M	24.07%	3
2022 Q3	$18.3M	Buy	1,294,785 +920,000	+245%	+$12.1M	17.62%	4
2022 Q2	$4.62M	Hold	374,785	–	–	8.57%	4
2022 Q1	$6.36M	Hold	374,785	–	–	10.77%	3
2021 Q4	$9.05M	Hold	374,785	–	–	9.21%	5
2021 Q3	$11M	Sell	374,785 -4	-0%	-$122	7.53%	5
2021 Q2	$9.5M	Hold	374,789	–	–	5.16%	5
2021 Q1	$7.25M	Hold	374,789	–	–	3.21%	6
2020 Q4	$5.51M	Buy	+374,789	New	+$8.01M	2.17%	6

Other funds holding WHWK

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

QVT Financial New York $1.37B AUM 148.1% 1-Year Est. Return

BCM

BML Capital Management Zionsville, Indiana $156M AUM 129.82% 1-Year Est. Return

ACP

Acuta Capital Partners Redwood City, California $142M AUM 783.79% 1-Year Est. Return

ACA

Acorn Capital Advisors New York $352M AUM 299.18% 1-Year Est. Return

ABG

Ally Bridge Group New York $124M AUM 249.88% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

PLC

Peapod Lane Capital Bedford Hills, New York $148M AUM 89.92% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

Alerce Investment Management's WHWK Position: Q4 2024 in Review

Alerce Investment Management held its Whitehawk Therapeutics (WHWK) position steady in Q4 2024 at 659 shares worth $2.08K. The position accounts for ﹤0.01% of the portfolio, ranked #5.

Alerce Investment Management first reported a position in WHWK in Q4 2020 and has held it in 17 quarters since. The position peaked at $20.9M in Q4 2022. 53 funds tracked by Wall St. Rank hold WHWK as of Q4 2024.

Alerce Investment Management held 659 shares of Whitehawk Therapeutics worth $2.08K as of Q4 2024.
Alerce Investment Management left its Whitehawk Therapeutics share count unchanged in Q4 2024.
Whitehawk Therapeutics made up ﹤0.01% of Alerce Investment Management's portfolio in Q4 2024, its #5 holding.
Alerce Investment Management first reported a position in Whitehawk Therapeutics in Q4 2020 and has held it in 17 quarters since.
Alerce Investment Management's Whitehawk Therapeutics position peaked at $20.9M in Q4 2022.
53 funds tracked by Wall St. Rank held Whitehawk Therapeutics as of Q4 2024.

Based on Alerce Investment Management's 13F filing for Q4 2024, filed 14 Feb 2025.